Antisocial personality disorder, psychopathy and injecting heroin use
Antisocial personality disorder, psychopathy and injecting heroin use
复制标题
DOI：
10.1016/s0376-8716(98)00058-1
复制
发表时间：
1998-09-01
影响因子：
4.2
通讯作者：
Finlay-Jones, R
中科院分区：
文献类型：
--
作者：
Darke, S;Kaye, S;Finlay-Jones, R
200名社区美沙酮患者（CM）; 200名监狱囚犯参加监狱美沙酮计划（PM）;和150名没有海洛因使用史（PNH）的监狱囚犯接受了采访，以获得反社会人格障碍（ASPD）和精神病检查表定义的精神病的诊断。所有三组中大部分受试者符合ASPD诊断标准（CM 44%，PM 65%，PNH 31%），两个美沙酮组的ASPD诊断比例显著高于非海洛因使用者。两组被诊断为精神病的比例没有差异（CM 4%，PM 9%，PNH 4%）。对于每一组，被诊断为反社会人格障碍的比例明显高于被诊断为精神病的比例。对ASPD诊断的意义进行了讨论。(C)1998爱思唯尔科学爱尔兰有限公司保留所有权利。
Two hundred community-based methadone patients (CM); 200 prison inmates enrolled in prison methadone programs (PM); and 150 prison inmates with no history of heroin use (PNH) were interviewed to obtain diagnoses of antisocial personality disorder (ASPD) and Psychopathy Checklist-defined psychopathy. Large proportions of subjects in all three groups met the criteria for a diagnosis of ASPD (CM 44%, PM 65%, PNH 31%), with the two methadone groups having significantly higher proportions of ASPD diagnoses than non-heroin users. There were no differences between groups in the proportions diagnosed as psychopathic (CM 4%, PM 9%, PNH 4%). For each group, the proportions diagnosed as ASPD were significantly higher than the proportions diagnosed as psychopathic. Implications for the diagnosis of ASPD are discussed. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.